User fees and access to ARV treatment for persons living with HIV/AIDS: Implementation and challenges in Burkina Faso, a limited-resource country

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 22, Issue 9, 2010, Pages 1146-1152

  Kouanda, S ^a   Bocoum, F Y ^a   Doulougou, B ^a   Bila, B ^a   Yameogo M ^a   Sanou, M J ^b   Sawadogo, M ^c   Sondo, B ^a   Msellati, P ^d   Desclaux, A ^c,d,e,f  

^a Institut de Recherche en Sciences de la Santé   (Burkina Faso)

^b MINISTÈRE DE LA SANTÉ   (Burkina Faso)

^c REGIPIV ^*  (Senegal)

^d UMR 145 IRD CreCSS   (France)

^e INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^f AIX MARSEILLE UNIVERSITY   (France)

Author keywords

access; ARV; Burkina Faso

Indexed keywords

ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT;

ADULT; AIDS PATIENT; ARTICLE; EMPLOYMENT; FEMALE; FOOD; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PATIENT TRANSPORT; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BURKINA FASO; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; FINANCING, PERSONAL; HEALTH EXPENDITURES; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INCOME; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POVERTY; YOUNG ADULT;

EID: 77956456433     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121003605047     Document Type: Article

References (40)

1. Boyer, S., Marcellin, F., Ongolo-Zogo, P., Abega, S.C., Nantchouang, R., Spire, B., & Moatti, J.P. (2009). Financial barriers to HIV treatment in Yaounde, Cameroon: First results of a national cross-sectional survey. Bulletin of World Health Organization, 87, 279-287.
2. Braitstein, P., Brinkhof, M.W., Dabis, F., Schechter, M., Boulle, A., Miotti, P.,. Egger, M. (2006). Mortality of HIV-1-infected patients in the first year of anti-retroviral therapy: Comparison between low-income and high-income countries. Lancet, 367, 817-824.
3. Brinkhof, M.W.G., Dabis, F., Myer, L., Bangsberg, D.R., Boulle, A., Nash, D.,. Anglaret, X. (2008). Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bulletin of World Health Organization, 86, 559-567.
4. Byakika-Tusiime, J., Oyugi, J.H., Tumwikirize, W.A., Katabira, E.T., Mugyenyi, P.N., & Bangsberg, D.R. (2005). Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. International Journal of STD & AIDS, 16, 38-41.
5. Canestri, A., Taverne, B., Thiam, S., Laurent, C, Ndir, A., Schiemann, R., & Landmann, R. (2002). Couts directs du suivi medical a la charge des patients hors antiretroviraux Direct costs of medical care to patients outside of antiretroviral treatment (in French). In A. Desclaux, I., Laniece, I. Ndoye, & B. Taverne (Eds.), Senegalese initiative of access to ART drugs: Economic, social, behavioral and medical analysis (in French) (pp. 55-66). Paris: Coll. Sciences Sociales et Sida, Editions ANRS.
6. Chabot, J. (1998). The Bamako initiative. Lancet, 2, 1366-1377.
7. Conseil National du SIDA, republique francaise (2007). Report on free care for people infected with HIV in developing countries (in French). Retrieved from http://www.cns.sante.fr/IMG/pdf/2007-02-15-rap-fr-politique- internationale.pdf
8. Desclaux, A. (2007). About the free of charge access to ARV treatments in Africa: Concretization of the utopian concept? (In French). In R. Mehdi & S. Maljean-Dubas (Eds.), The international society and the great pandemics (pp. 195-202). Paris: Pedone.
9. Ensor, T., & Cooper, S. (2004). Overcoming barriers to health service access: Influencing the demand side. Health Policy and Planning, 19, 69-79.
10. Fleutelot, E. (2004, September/November). Free access to care and treatment: A community perspective (in French). Transcriptases 118. Retrieved from http://www.pistes.fr/transcriptases/118-404.htm
11. Gilks, C.F., Crowley, S., Ekpini, R., Gove, S., Perriens, J., Souteyrand, Y.,. De CocK, K. (2006). The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet, 368, 505-510.
12. Gilson, L., Kalyalya, D., Kuchler, F., Lake, S., Organa, H., & Ouendo, M. (2000). The equity impacts of community financing activities in three African countries. The International Journal of Health Planning and Management, 15, 291-317.
13. Haddad, S., & Fournier, P. (1995). Quality, cost and utilization of health services in developing countries. A longitudinal study in Zare. Social Science & Medicine, 40(6), 743-753.
14. Holmes, W. (2004). 3 by 5, but at what cost. Lancet, 363, 1072-1073.
15. Institut National de la Statistique et de la Demographie (INSD), Burkina Faso (2003). Survey on the life conditions of household in Burkina Faso 2003 (in French). Ovagadugov, Burkina Faso: INSD.
16. IrinNews (2007, December 5). Burkina Faso: The government announces the reduction of ARV cost (in French). Retrieved from http://www.irinnews.org/fr/ ReportFrench.aspx?ReportId=75706
17. James, CD., Hanson, K., McPake, B., Balabanova, D., Gwatkin, D., Hopwood, I.,. Xu, K. (2006). To retain or remove user fees? Reflections on the current debate in low-and middle-income countries. Applied Health Economics Health Policy, 5(3), 137-153.
18. Kouanda, S., Bila, B., Berthe, A., Doulougou, B., Meda, N., Msellati, P., et al. (2008). Practices of management of persons living with HIV/AIDS in Burkina Faso (in French). Research report, 113 p. Ovagadugov, Burkina Faso.
19. Laniece, I., Ciss, M., Desclaux, A., Diop, K., Mbodj, F., Ndiaye, B.,.Mdoye, I. (2003). Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS, 17(Suppl. 3), S103-S108.
20. McIntyre, D., Thiede, M., Dahlgren, G., & Whitehead, M. (2006). What are the economic consequences for households of illness and of paying forhealth care in low-and middle-income country contexts? Social Science & Medicine, 62, 858-865.
21. Mills, E.J., Nachega, J.B., Bangsberg, D.R., Singh, S., Rachlis, B., Wu, P.,. Cooper, C. (2006a). Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Medicine, 3, e438.
22. Mills, E.J., Nachega, J.B., Buchan, I., Orbinski, J., Attaran, A., Singh, S.,. Bangsberg, D.R. (2006b). Adherence to antiretroviral treatment in sub-Saharan Africa and North America: A meta-analysis. JAMA, 296, 679-690.
23. Mukherjee, J. (2004). Basing treatment on rights rather than ability to pay. Lancet, 363, 1071-1072.
24. Nguyen, V.K., Grennan, T., Peschard, K., Tan, D., & Tiendrebeogo, I. (2003). Antiretroviral use in Ouagadougou. AIDS, 17(Suppl. 3), S109\S111.
25. Palmer, N., Mueller, D.H., Gilson, L., Mills, A., & Haines, A. (2004). Health financing to promote access in low income settings-how much do we know? Lancet, 364, 1365-1370.
26. Pierson, R., & Ntata, T. (2007). Equity in access to ARV drugs in Malawi. Journal of Social Aspects of HIV/AIDS, 4(1), 564-574.
27. Reniers, G., Araya, T., Davey, G., Nagelkerke, N., Berhane, Y., Coutinho, R., & Sanders, E.J. (2009). Steep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, Ethiopia. AIDS, 23, 511-518.
28. Ridde, V. (2003). Fees-for-services, cost recovery, and equity in a district of Burkina Faso operating Bamako initiative. Bulletin of World Health Organization, 81(7), 532-538.
29. Ridde, V. (2008). The problem of the worst-off is dealt with afterall otherissues: The equity and health policy implementation gap in Burkina Faso. Social Science & Medicine, 66, 1368-1378.
30. Shargie, E.B., & Lindtjorn, B. (2007). Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia. PLoS Medicine, 4(2), e37.
31. Some, P.A., & Ridde, V. (2009). Study on selection criterion of beneficiaries of the exemption of ARV payment in Burkina Faso (47 p.). Research report. Montreal: University of Montreal.
32. Souteyrand, Y., Collard, V., Moatti, J.P., Grubb, I., & Guerma, T. (2008). Free care at the point of service delivery: A key component for reaching universal access to HIV/AIDS treatment in developing countries. AIDS, 22, 161-168.
33. Stierle, F., Kadar, M., Tchicaya, A., & Schmidt-Ehry, B. (1999). Indigence and access to health care in sub-Saharan Africa. The International Journal of Health Planning and Management, 14(2), 81-105.
34. Taverne, B. (2005). Gratuity of Aids treatment in Africa: a public health imperative in population, development and HIV/AIDS and their relations with poverty (in French). Communication in the 38th session of the Commission of population and development of United Nations Organization, New York.
35. UNAIDS (2008). 2008 report on the global AIDS epidemic. Retrieved from http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/ 2008-Global-report.asp
36. United Nations Development Programme [UNDP] (2009). Human development report 2009. Overcoming barriers: Human mobility and development. Retrieved from http://hdr.undp.org/en/media/HDR-2009-EN-Complete.pdf
37. WHO, UNAIDS, & UNICEF (2008). Epidemiological fact sheet on HIV and AIDS. Core data on epidemiology and response. Burkina Faso. 2008 update. Retrieved from http://apps.who.int/globalatlas/predefinedReports/EFS2008/full/ EFS2008-BF.pdf WHO
38. World Health Organization [WHO] (2006). Towards universal access by 2010. How WHO is working with countries to scale up HIV prevention, treatment, care and support (31 pp.). Geneva: Author.
39. Zachariah, R., Harries, A.D., Manzi, M., Gomani, P., Teck, R., Phillips, M., & Firmenich, P. (2006). Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One, 1(1), 121.
40. Zachariah, R., Van Engelgem, I., Massaquoi, M., Kocholla, L., Manzi, M., Suleh, A.,. Borgdorff, M. (2008). Payment for antiretroviral drugs is associated with a higherrate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene, 102(3), 288-293.